This month we’ve learned about sleep quality after MDMA, microdosing leaves creativity hanging, and an exciting Phase II study with nitrous oxide was published. The debate on the mystical experience continues, fMRI studies are standing on a small foundation, and some encounter entities after smoking DMT. What if no study uses the same methodology, can you then still generalize the results that a…


Previous articlePsyBio Therapeutics Augments Intellectual Property Portfolio with Filing of Next Novel Psychedelic Compositions and Methods of Treatment Patent
Next articleActive vs. Passive Coping Distinguishes Antidepressants and Psychedelics